Exact Mass: 265.0215
Exact Mass Matches: 265.0215
Found 233 metabolites which its exact mass value is equals to given mass value 265.0215,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bropirimine
D007155 - Immunologic Factors > D007369 - Interferon Inducers C308 - Immunotherapeutic Agent > C2139 - Immunostimulant D000970 - Antineoplastic Agents Same as: D01666
Isoniazid alpha-ketoglutaric acid
Isoniazid alpha-ketoglutaric acid is a metabolite of isoniazid. Isoniazid (Laniazid, Nydrazid), also known as isonicotinylhydrazine (INH), is an organic compound that is the first-line medication in prevention and treatment of tuberculosis. (Wikipedia)
Desacetyl-nitazoxanide
Desacetyl-nitazoxanide is a metabolite of lamivudine. Lamivudine (2,3-dideoxy-3-thiacytidine, commonly called 3TC) is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). It is marketed by GlaxoSmithKline with the brand names Zeffix, Heptovir, Epivir, and Epivir-HBV. Lamivudine has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV. It improves the seroconversion of e-antigen positive hepatitis B and also improves histology staging of the liver. (Wikipedia) D000890 - Anti-Infective Agents
Nitecapone
Nitecapone belongs to the family of Nitrophenols and Derivatives. These are compounds containing a nitrophenol moiety, which consists of a benzene ring bearing both an hydroxyl group and a nitro group on two different ring carbon atoms. D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D020011 - Protective Agents > D000975 - Antioxidants C471 - Enzyme Inhibitor
(2-Carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl) hydrogen sulfate
makaluvamine N
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D004791 - Enzyme Inhibitors
3-(1H-Imidazol-4-yl)-2-(2-thienylsulfonyl)acrylonitrile
2-amino-3,4,5,6-tetrahydro-4,6-dioxo-7-pteridinepyruvic acid
Benzenesulfonamide, 4-amino-N-(5-hydroxy-2-pyridinyl)-
2-Hydroxysaclofen
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists
Clonidine hydrochloride
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics Clonidine hydrochloride is an agonist of α2-adrenoceptor and potent antihypertensive agent.
2-OH-Saclofen
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists
Nitecapone
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D020011 - Protective Agents > D000975 - Antioxidants C471 - Enzyme Inhibitor
4-(4-METHANESULFONYL-BENZYLIDENE)-2-METHYL-4H-OXAZOL-5-ONE
1-CYCLOPROPYL-6,7-DIFLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID
ethyl 3-methyl-5-nitro-benzothiophene-2-carboxylate
6-Amino-1,7-dihydro-2H-purine-2-thione sulfate (1:1)
5(4H)-OXAZOLONE, 4-[(2-BROMOPHENYL)METHYLENE]-2-METHYL-
5(4H)-OXAZOLONE, 4-[(4-BROMOPHENYL)METHYLENE]-2-METHYL-
3-amino-2-hydroxy-[1,1-biphenyl]-3-carboxylic acid hydrochloride
2-(1,3-dioxoisoindol-2-yl)-3-methylsulfanylpropanoic acid
2-(2,3-DIHYDRO-1-BENZOFURAN-5-YL)THIAZOLE-4-CARBONYL CHLORIDE,
4-(4-Methylphenylsulfonyl)semicarbazide hydrochloride
7-BROMO-3,4,10,10A-TETRAHYDRO-2H-PYRANO[2,3-B]QUINOLINE
1-(3,4-Difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid
(2-amino-4,5-dimethylthiophen-3-yl)(4-chlorophenyl)methanone
ETHYL 3-AMINO-1-(4-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
3-AMINO-3-[5-(2-CHLOROPHENYL)-FURAN-2-YL]-PROPIONIC ACID
3-AMINO-3-[5-(3-CHLOROPHENYL)-FURAN-2-YL]-PROPIONIC ACID
4-(2,6-difluoro-4-methylbenzoyl)-1H-pyrrole-2-carboxylic acid
ETHYL 2-AMINO-4-(4-FLUOROPHENYL)THIOPHENE-3-CARBOXYLATE
ethyl 6-methyl-5-nitro-1-benzothiophene-2-carboxylate
{[4-(4-METHOXYPHENYL)-4H-1,2,4-TRIAZOL-3-YL]THIO}ACETIC ACID
4-FLUORO-3-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-2-CARBONITRILE
4-FLUORO-3-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-3-CARBONITRILE
Ethyl 1-(3-chloropyridin-2-yl)-5-methyl-1H-pyrazole-4-carboxylate
Ethyl 1-(6-chloropyridin-2-yl)-5-methyl-1H-pyrazole-4-carboxylate
4-HYDROXYMETHYL-3-(4-NITRO-BENZYL)-2-MERCAPTO-3H-IMIDAZOLE
Avibactam
A member of the class of azabicycloalkanes that is (2S,5R)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide in which the amino hydrogen at position 6 is replaced by a sulfooxy group. Used (in the form of its sodium salt) in combination with ceftazidime pentahydrate for the treatment of complicated urinary tract infections including pyelonephritis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors D004791 - Enzyme Inhibitors
3-(4-Bromophenyl)-5-methyl-1,2-oxazole-4-carbaldehyde
methyl 6-chloro-2-(4-fluorophenyl)pyridine-3-carboxylate
1-[3-chloro-5-(trifluoromethyl)pyrid-2-yl]piperazine
ETHYL5-AMINO-1-(4-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
(2-(ISOPROPYLTHIO)-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)BORONIC ACID
5-(2-Methyl-4-nitrophenyl)furan-2-carbonyl chloride
5-bromo-6-methyl-2-pyridin-2-yl-1H-pyrimidin-4-one
5,6-DIHYDRO-4H-4-HYDROXY-6-METHYLTHIENO[2,3-B]THIOPYRAN-2-SULPHONAMIDE
(2-AMINO-5-ETHYLTHIOPHEN-3-YL)(2-CHLOROPHENYL)METHANONE
METHYL 3-(2-CHLOROPHENYL)-5-FORMYLISOXAZOLE-4-CARBOXYLATE
METHYL 3-(4-CHLOROPHENYL)-5-FORMYLISOXAZOLE-4-CARBOXYLATE
3-[N,N-Bis(hydroxyethyl)amino]-2-hydroxypropanesulphonic acid sodium salt
2-CHLORO-1-[1-(4-FLUOROPHENYL)-2,5-DIMETHYL-1H-PYRROL-3-YL]-1-ETHANONE
5-AMINO-1-(2-CHLORO-PHENYL)-1H-PYRAZOLE-4-CARBOXYLICACIDETHYLESTER
2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-amine hydrochloride
9-BROMO-2,3,4,5-TETRAHYDRO-1H-BENZO[4,5]IMIDAZO[1,2-D][1,4]DIAZEPINE
5-AMINO-1-(2-CHLORO-PHENYL)-1H-PYRAZOLE-3-CARBOXYLICACIDETHYLESTER
Pyridoxal phosphate hydrate
D018977 - Micronutrients > D014815 - Vitamins Pyridoxal 5'-phosphate hydrate, the active form of vitamin B6, is an essential cofactor for multiple enzymes, including aromatic l-amino acid decarboxylase that catalyzes the final stage in the production of the neurotransmitters dopamine and serotonin. Pyridoxal 5'-phosphate hydrate is the most important coenzyme variant in the process of vitamin B6 intracellular phosphorylation and is interconvertible with other variants, including pyridoxine 5′‐phosphate (PNP) and pyridoxamine 5′‐phosphate (PMP)[1][2].
4-ALLYL-5-[(4-FLUOROPHENOXY)METHYL]-4H-1,2,4-TRIAZOLE-3-THIOL
4-Thiazolidinone,5-(1,3-benzodioxol-5-ylmethylene)-2-thioxo-
8-BROMO-2,3,4,5-TETRAHYDRO-1H-BENZO[4,5]IMIDAZO[1,2-D][1,4]DIAZEPINE
Ethyl 3-amino-3-(3,5-difluorophenyl)propionate hydrochloride
2-AMINO-4-(4-FLUOROPHENYL)-5-METHYLTHIOPHENE-3-CARBOXYLICACIDMETHYLESTER
2-AMINO-8-PYRIDIN-3-YL-7,9-DIOXA-1-THIA-3-AZA-SPIRO[4.5]DEC-2-EN-4-ONE
8-AMINO-4-0X0-2-[1H -TETRAZOLE-5YL ) 4H-1-BENZOPYRAN HYDROCHLORIDE
ETHYL5-AMINO-1-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
2,4(1H,3H)-Pyrimidinedione,5-[bis(2-chloroethyl)amino]-6-methyl-
2-OXO-6-PYRIDIN-3-YL-4-(TRIFLUOROMETHYL)-1,2-DIHYDROPYRIDINE-3-CARBONITRILE
6-Chloro-4-nitro-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine
4-Chloro-3-nitro-5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine
ETHYL 5-CYANO-3,4-DIMETHYLTHIENO[2,3-B]THIOPHENE-2-CARBOXYLATE
2-(4-chlorophenyl)sulfanylpyridine-3-carboxylic acid
ETHYL 4-(CHLOROSULFONYL)-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLATE
1-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]piperidine-4-carbaldehyde
Acetamide,N-[5-[(phenylmethyl)thio]-1,3,4-thiadiazol-2-yl]-
N-(5-acetyl-3-fluoro-6-oxocyclohexa-2,4-dien-1-ylidene)-2,3-dihydro-1H-tetrazole-5-carboxamide
3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]benzonitrile
2-Chloromethyl-3-Methyl-4-(3-Methoxypropoxy)Pyridine Hydrochloride
4-Thiazolidinone,5-[(2-ethoxyphenyl)methylene]-2-thioxo-
2-CHLORO-N-[2-(2,4-DICHLORO-PHENYL)-ETHYL]-ACETAMIDE
3-Quinolinecarboxylicacid, 7-chloro-4-hydroxy-8-methyl-, ethyl ester
5-CHLORO-4-(4-METHYL-3-NITROPHENYL)PYRIDAZIN-3(2H)-ONE
1-[2-(4-chlorophenoxy)-5-fluorophenyl]-N-methylmethanamine
2-PYRIDIN-4-YL-1-(4-TRIFLUOROMETHYL-PHENYL)-ETHANONE
Ethyl 5-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate
2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid
(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate
(S)-3-(4-Chloro-benzenesulfinyl)-pyrrolidine hydrochloride
Org 12962
Org-12962 is a potent, selective and orally active 5-HT2C?receptor agonist with a pEC50?value of 7.01. Org-12962 also exhibits high effacy for the 5-HT2A?and 5-HT2B receptor with pEC50s of 6.38 and 6.28, respectively[1][3].Org-12962 displays antiaversive effects in a rat model of panic-like anxiety[2].
1H-Indole-3-carboxaldehyde,5-bromo-1-(1-methylethyl)-(9CI)
2-fluoro-5-[(Z)-(3-oxo-2-benzofuran-1-ylidene)methyl]benzonitrile
3-(ETHYLTHIO)-6,6-DIMETHYL-4-OXO-4,5,6,7-TETRAHYDROBENZO[C]THIOPHENE-1-CARBONITRILE
7-Chloro-8-fluoro-2-(trifluoromethyl)quinolin-4-ol
4-Hydrazino-N-metyl benzene ethane sulfonamide hydrochloride
1-(2-BROMOPHENYL)-2-(1H-1,2,4-TRIAZOLE-1-YL)-ETHANONE
Benzoic acid,2-[(4-oxo-2-thioxo-5-thiazolidinylidene)methyl]-
6-chloro-4-hydroxy-8-methylquinoline-3-carboxylic ethyl ester
1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-4-(4-CHLOROPHENYL)-3-PYRIDINECARBOXYLIC ACID
4-ISOXAZOLECARBOXYLIC ACID, 3-(4-CHLOROPHENYL)-5-METHYL-, ETHYL ESTER
4-[(6-Amino-4-pyrimidinyl)amino]benzenesulfonamide
N-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamic acid methyl ester
1-[4-(4-Chlorophenyl)thiazol-2-yl]-2-(propan-2-ylidene)hydrazine
2-chloro-N-(4,7-dimethyl-2-oxo-1-benzopyran-6-yl)acetamide
2-(3-Benzyl-2,4-dioxo-1,3-thiazolidin-5-yl)acetic acid
1-(3,4-Dihydroxyphenyl)-2-[(4-methyl-1,2,4-triazol-3-yl)thio]ethanone
(1E,2E)-N-[(Pentafluorophenyl)methoxy]but-2-en-1-imine
Ferric ammonium citrate
V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds
Amiloride hydrochloride
D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062686 - Epithelial Sodium Channel Blockers D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062646 - Acid Sensing Ion Channel Blockers D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
2-(3,4-Dichlorophenyl)-2,3-dihydro-1,3-benzoxazole
N,N-diethyl-5-thiophen-2-yl-2-thiophenecarboxamide
(5E)-5-[(2-hydroxy-3-nitrophenyl)methylidene]-2-sulfanylideneimidazolidin-4-one
N-[3-(methylthio)-1,2,4-thiadiazol-5-yl]-2-phenylacetamide
6-chloro-2-[(1H-1,2,4-triazol-5-ylthio)methyl]imidazo[1,2-a]pyridine
N-(5-methyl-4,5-dihydrothiazol-2-yl)-3-nitrobenzamide
Sulfapyridine hydroxylamine
A pyridine having a 4-hydroxyaminobenzenesulfonamido group at the 2-position.
10-amino-9-bromo-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one
3-(4-hydroxy-2-imino-6-oxo-1,5-dihydropteridin-7-yl)-2-oxopropanoic acid
(3Z)-3-(2-amino-4,6-dioxo-5,8-dihydro-1H-pteridin-7-ylidene)-2-oxopropanoic acid
{"Ingredient_id": "HBIN009763","Ingredient_name": "(3Z)-3-(2-amino-4,6-dioxo-5,8-dihydro-1H-pteridin-7-ylidene)-2-oxopropanoic acid","Alias": "(3Z)-3-(2-amino-4,6-dioxo-5,8-dihydro-1H-pteridin-7-ylidene)-2-oxo-propanoic acid; (3Z)-3-(2-amino-4,6-diketo-5,8-dihydro-1H-pteridin-7-ylidene)-2-keto-propionic acid; 3-(2-Amino-4,5,6,8-tetrahydro-4,6-dioxopteridin-7(3H)-ylidene)-2-oxopropionic acid; 7449-03-8; EINECS 231-214-4","Ingredient_formula": "C9H7N5O5","Ingredient_Smile": "C(=C(C(=O)O)O)C1=NC2=C(C(=O)NC(=N2)N)NC1=O","Ingredient_weight": "265.18 g/mol","OB_score": "10.6551606","CAS_id": "7449/3/8","SymMap_id": "SMIT12555","TCMID_id": "NA","TCMSP_id": "MOL011684","TCM_ID_id": "NA","PubChem_id": "136217907","DrugBank_id": "NA"}
